Antibacterial activity and cytotoxycity of gelatine‐conjugated lysine‐based peptides
Source abstract
Abstract
Abstract The effect of the coupling approach (chemical by using carbodiimide chemistry, and enzymatic by using transglutaminase) of a hydrophilic ɛ‐poly‐L‐lysine (ɛPL) and a structurally‐hydrophobic oligo‐acyl‐lysyl (OAK) to a gelatine (GEL) macromolecule, and their antibacterial activity against Gram‐negative E. coli and Gram‐positive S. aureus bacteria, as well as cytotoxicity to human osteoblast cells was studied as potential macromolecules for biomedical applications. Different spectroscopic (ultraviolet‐visible, infrared, fluorescence, and electron paramagnetic resonance) and separation (size‐exclusion chromatography and capillary zone electrophoresis) techniques, as well as zeta‐potential analysis were performed to confirm the ɛPL/OAK covalent coupling and to determine their amount and orientation of the immobilization. The highest and kinetically the fastest reduction of bacteria (≥77% against E. coli vs. ≥82% against S. aureus) was achieved with GEL functionalized with ɛPL/OAK by the chemical grafting‐to approach being correlated with conformationally the highly‐flexible ˝brush‐like˝ orientation linkage of peptides, enable its targeted and rapid interactions with bacteria membrane. The up to 400‐fold lower yield of OAKs being immobilized may be related also to its cationic charge and hydrophobic alkyl chain moieties, compared to more hydrophilic ɛPL easily causing random polymerization and self‐conjugation. The ɛPL/OAK‐functionalized GEL did not induce citotoxicity to osteoblasts, even at ∼25‐fold higher concentration than bacterial minimum inhibitory (MIC) concentration of ɛPL/OAK. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 3110–3126, 2017.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Antimicrobial Peptides and Activities · Antimicrobial agents and applications · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Faculty of Mechanical Engineering, Institute of Engineering Materials and Design University of Maribor Maribor Slovenia
Department of Biotechnology & Food Engineering Technion‐Israel Institute of Technology Haifa Israel
Funding
Slovenian Ministry of Education, Science, Culture and Sport under the Era-Net MATERA Plus Programme
References (88)
Show source-provided references
1. Laverty G · 2014 · 1945
2. Biofilm and orthopaedic implant infection
3. 10.3390/ijms16092171110.3390/ijms160921711 ↗
4. 10.1016/j.biomaterials.2013.07.08910.1016/j.biomaterials.2013.07.089 ↗
5. 10.1038/pj.2012.13010.1038/pj.2012.130 ↗
6. 10.3390/polym401004610.3390/polym4010046 ↗
7. 10.3390/ijerph12050565710.3390/ijerph120505657 ↗
8. 10.1038/nbt126710.1038/nbt1267 ↗
9. 10.1007/978-3-319-32949-9_810.1007/978-3-319-32949-9_8 ↗
10. 10.1038/nbt130910.1038/nbt1309 ↗
11. 10.1096/fj.07-10501510.1096/fj.07-105015 ↗
12. 10.1096/fj.09-14942710.1096/fj.09-149427 ↗
13. 10.1016/j.chembiol.2009.11.01210.1016/j.chembiol.2009.11.012 ↗
14. 10.1016/j.actbio.2010.11.00510.1016/j.actbio.2010.11.005 ↗
15. 10.1128/AEM.00532-1010.1128/AEM.00532-10 ↗
16. 10.1128/AEM.02537-1410.1128/AEM.02537-14 ↗
17. 10.1002/jbm.a.3526110.1002/jbm.a.35261 ↗
18. 10.1002/jbm.a.3507610.1002/jbm.a.35076 ↗
19. 10.1002/adma.20140335410.1002/adma.201403354 ↗
20. 10.1021/bm060684o10.1021/bm060684o ↗
21. 10.5772/195710.5772/1957 ↗
22. 10.1016/j.biomaterials.2010.12.04010.1016/j.biomaterials.2010.12.040 ↗
23. 10.1177/088391151561001910.1177/0883911515610019 ↗
24. 10.1007/978-3-540-73865-7_1110.1007/978-3-540-73865-7_11 ↗
25. Wong SS. · 2000
26. Hermanson GT. · 2008
27. 10.1016/j.enzmictec.2003.08.00410.1016/j.enzmictec.2003.08.004 ↗
28. Jones RT. · 2004 · 2361
29. 10.1006/abio.1997.216110.1006/abio.1997.2161 ↗
30. 10.1039/c0ay00116c10.1039/c0ay00116c ↗
31. 10.3144/expresspolymlett.2015.1610.3144/expresspolymlett.2015.16 ↗
32. 10.1016/0003-2697(92)90513-710.1016/0003-2697(92)90513-7 ↗
33. 10.1016/0003-2697(66)90275-210.1016/0003-2697(66)90275-2 ↗
34. 10.1016/0003-2697(76)90527-310.1016/0003-2697(76)90527-3 ↗
35. 10.15623/ijret.2015.040202510.15623/ijret.2015.0402025 ↗
36. 10.1016/j.chroma.2009.10.08110.1016/j.chroma.2009.10.081 ↗
37. 10.1080/10826076.2012.74372410.1080/10826076.2012.743724 ↗
38. Analysis of catecholamines and related compounds in one whole metabolic pathway with high performance liquid chromatography based on derivatization
39. Lorian V. · 2005 · 52
40. E2149–10: Standard test method for determining the antimicrobial activity of immobilised antimicrobial agents under dynamic contact conditions. ASTM International: West Conshohocken USA.
41. 10.1016/j.ijbiomac.2008.02.00410.1016/j.ijbiomac.2008.02.004 ↗
42. 10.3390/ma303186310.3390/ma3031863 ↗
43. 10.1080/1071754080190512410.1080/10717540801905124 ↗
44. 10.1007/s00289-014-1108-310.1007/s00289-014-1108-3 ↗
45. Characterisation and quantification of the reaction(s)catalysed by transglutaminase using the o‐phthaldialdehyde reagent
46. 10.1111/j.1745-4603.2006.00042.x10.1111/j.1745-4603.2006.00042.x ↗
47. Improvement of gluten‐free bread quality using transglutaminase; various extruded flours and protein isolates
48. 10.1007/s00253-003-1539-510.1007/s00253-003-1539-5 ↗
49. 10.1007/s00253-012-4569-z10.1007/s00253-012-4569-z ↗
50. 10.1007/978-1-4419-1478-110.1007/978-1-4419-1478-1 ↗
51. Gelatine fluorescence and its relationship to animal age and gelatine colour
52. 10.1007/s10856-015-5508-110.1007/s10856-015-5508-1 ↗
53. 10.1016/0001-8686(74)85002-510.1016/0001-8686(74)85002-5 ↗
54. 10.1007/s00396-014-3276-y10.1007/s00396-014-3276-y ↗
55. 10.1016/j.bbamem.2006.09.01510.1016/j.bbamem.2006.09.015 ↗
56. 10.1128/AAC.00656-0810.1128/AAC.00656-08 ↗
57. 10.1021/jp111242q10.1021/jp111242q ↗
58. Pullulan as molecular weight standard for gelatin
59. 10.1007/BF0249200710.1007/BF02492007 ↗
60. 10.1021/ac00121a00410.1021/ac00121a004 ↗
61. Pritchett T · 1994
62. 10.1021/ac00036a02110.1021/ac00036a021 ↗
63. 10.1002/(SICI)1521-3927(19980901)19:9<473::AID-MARC473>3.0.CO;2-X10.1002/(SICI)1521-3927(19980901)19:9<473::AID-MARC473>3.0.CO;2-X ↗
64. 10.1021/ci050149010.1021/ci0501490 ↗
65. 10.3389/fmolb.2015.0002110.3389/fmolb.2015.00021 ↗
66. 10.1016/0076-6879(95)46026-810.1016/0076-6879(95)46026-8 ↗
67. 10.1002/jhet.557042031110.1002/jhet.5570420311 ↗
68. 10.7164/antibiotics.37.144910.7164/antibiotics.37.1449 ↗
69. 10.1007/s10529-010-0294-910.1007/s10529-010-0294-9 ↗
70. 10.1007/s00253-003-1312-910.1007/s00253-003-1312-9 ↗
71. 10.3402/fnr.v60.3189110.3402/fnr.v60.31891 ↗
72. 10.1128/AAC.00689-1110.1128/AAC.00689-11 ↗
73. 10.1038/415389a10.1038/415389a ↗
74. 10.1074/jbc.M110.13095510.1074/jbc.M110.130955 ↗
75. 10.1038/srep0957810.1038/srep09578 ↗
76. 10.1186/s40064-015-1476-710.1186/s40064-015-1476-7 ↗
77. 10.1155/2013/74616510.1155/2013/746165 ↗
78. 10.1128/AAC.43.6.131710.1128/AAC.43.6.1317 ↗
79. 10.1016/S0966-842X(97)81773-810.1016/S0966-842X(97)81773-8 ↗
80. 10.1002/1097-0282(2000)55:1<4::AID-BIP30>3.0.CO;2-M10.1002/1097-0282(2000)55:1<4::AID-BIP30>3.0.CO;2-M ↗
81. 10.1021/es803150610.1021/es8031506 ↗
82. 10.1016/j.foodcont.2014.02.02310.1016/j.foodcont.2014.02.023 ↗
83. 10.1007/s12602-009-9020-010.1007/s12602-009-9020-0 ↗
84. ISO 10993–5:2009(E). Biological evaluation of medical devices – Part 5: Tests for in vitro cytotoxicity.
85. 10.1016/j.bcp.2006.01.01210.1016/j.bcp.2006.01.012 ↗
86. 10.1007/s00284-009-9490-z10.1007/s00284-009-9490-z ↗
87. 10.1128/AAC.00511-1210.1128/AAC.00511-12 ↗
88. 10.1016/j.bbamem.2010.09.01310.1016/j.bbamem.2010.09.013 ↗